Richmond Pharmacology supporting clinical facilities in Nicaragua

Posted:
30
January 2020

Richmond Pharmacology have developed a resourceful way to use study equipment to help reduce waste produced on site and support clinical facilities in under developed nations.

Richmond Pharmacology have developed a resourceful way to use study equipment to help reduce waste produced on site and support clinical facilities in under developed nations. The initiative is the idea of Jennifer Cripps, and her colleagues Kadeem Marshall and Eleanor Wright, who are all Clinical Trials Assistants at Richmond Pharmacology.  

As part of Richmond Pharmacology’s ongoing study activity, we receive excess needles and vacutainers as part of wider supplies onsite to aid taking blood. Richmond Pharmacology already have their own certified supplies of blood collection consumables, meaning needles which are unused have to be discarded. Jennifer and her team thought there would be a better use of the equipment and began investigating a better destination for the excess supplies.

Through her research, a relationship with the Nilda Patricia Hospital in Nicaragua has been established and this month Richmond Pharmacology arranged for over 350 needles and vacutainers to be sent to the hospital which would have otherwise been unused and discarded.

The scheme is increasingly important as Nilda Patricia Hospital suffer from lack of resources, and therefore have come to rely on donations from outside the country in order to upgrade their own resources.

The needles come packaged and are sterile, which the hospital are in high demand of and are particularly useful as they can be used in the wider community, where mobile clinics go out to rural areas to treat patients who cannot easily get to the hospital.

The hospital also has a twinning agreement with George Eliot hospital in Nuneaton. Their arrangement has also helped to provide basic things such as rubber gloves and other basic equipment.

The plan is to maintain this relationship and supply the hospital with supplies that would otherwise go to waste every 3 months and forms part of Richmond Pharmacology’s wider plan to be more resourceful with our intake of study supplies and support clinical facilities worldwide.

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more